Female infertility. Female infertility, unspecified
Conditions
Interventions
Intervention 1: Intervention: 300 microgram granulocyte colony stimulating factor is injected into the uterus in the 13th day of menstural cycle. Intervention 2: Control: In the control group, no dr
Treatment - Drugs
Intervention: 300 microgram granulocyte colony stimulating factor is injected into the uterus in the 13th day of menstural cycle.
Control: In the control group, no drug is injected into the uterus in the 13th day of menstural cycle.
Sponsors
Yazd reaserch and clinical center for infertility
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: all patients with thin endometrium in spite of receiving standard treatment in 12-13th day of frozen-thawed embryo transfer cycle. Exclusion criteria: all patient with history of hypersensitivity to G-CSF; endocrine or systemic diseases; endometriosis; repeated implantation failure; repeated abortion; patients with any cogenital uterine anomaly or aquired uterine diseases with or without operation; age below 20 years; age above 40 years.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Endometrial thickness. Timepoint: 13th and 17th day of menstural cycle. Method of measurement: vaginal sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Chemical pregnancy. Timepoint: 14 days after embryo transfer. Method of measurement: serum Bhcg.;Clinical pregnancy. Timepoint: 28 days after embryo transfer. Method of measurement: vaginal sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Eftekhar
Yazd reaserch and clinical center for infertility
Outcome results
None listed